ARCHIVES

Rescission Cuts $5-6 Mil. From NCI FY94 Appropriations , Affects Intramural Program

This article is from The Cancer Letter archive.

Vol. 20 No. 10 | March 11, 1994

Download PDF Visit The Full Archive

Related Articles

Senate Report Calls For Review Of Progress In Cancer Program Restores Prevention And Control Funding

September 18, 1992

Phase III Trial of Imbruvica Halted, Following Increases in Progression-Free Survival

January 31, 2014

NCI-Approved Clinical Trials

July 28, 2006

In Brief: MSK Opens Laurence Rockefeller Pavilion; Bush Event raised 410 Million for Anderson

July 9, 1999

Study Links Exercise and Survival In Breast and Colon Cancer Mortality

May 25, 2012

NCI-Approved Clinical Trials

October 29, 2004